Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Novel treatments for the mucus accumulation at chronic lung diseases

Project description

New therapies for chronic lung diseases

The goal of the EU-funded MUC2GO proof-of-concept project is to develop novel therapies for cystic fibrosis, chronic bronchitis, chronic obstructive pulmonary disease (COPD) and other lung diseases presenting with mucus accumulation. The project is based on the previous discovery that a protein that is absent in healthy individuals and animals is found in increased amounts in human COPD and induced lung disease in animal models. This protein forms large polymers by non-covalent interactions and anchors and attaches the lung mucus via cap formation. The current project aims to develop inhibitory peptides, proteins, antibodies and small molecules as therapeutic drugs for detaching the mucus to treat lung diseases with mucus accumulation.

Objective

The aim of this proof of concept is to develop novel therapies based on the discoveries made during the AdvERC grant on mucus and mucins in the lung and intestine. The discovery that the XX protein is absent or almost absent in healthy individuals and animals and heavily increased in human COPD and induced lung disease in animals made us study this. During the ERC grant we discoverd that XX is anchoring and attaching the lung mucus by forming a cap on the accumulated mucus. In the absence of XX the mucus is non-attached and transported even better than normal. We have now determined the detailed molecular structure of the XX and learnt how this protein can form long, large polymers by non-covalent interactions. We will now develop inhibitory peptides, proteins, antibodies or small organic molecules to be used as therapeutic drugs for detaching the attached mucus at Cystic Fibrosis, Chronic bronchitis, COPD, and other lung diseases with mucus accumulation.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-POC2

See all projects funded under this call

Host institution

GOETEBORGS UNIVERSITET
Net EU contribution
€ 150 000,00
Address
VASAPARKEN
405 30 Goeteborg
Sweden
Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)